Kailo Pharma is an Israeli medical startup commercializing University of Haifa research aimed at directly treating PTSD. Its lead approach targets a newly identified brain mechanism tied to pathological amplification of traumatic memories, with the goal of weakening trauma intensity without erasing normal memory. The company is developing a peptide-based therapy intended for nasal delivery to reach the central nervous system.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Kailo Pharma Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Mar 22, 2026
www.calcalistech.com
Israeli startup seeks to redefine PTSD treatment with novel brain mechanism
null
Mar 22, 2026
www.calcalist.co.il
להתגבר על פוסט־טראומה? חברה ישראלית מנסה לפתח תרופה שתנטרל זיכרון פתולוגי